By Professor Lisa Maher

Journal articles

Prestage G; Hammoud M; Jin F; Degenhardt L; Bourne A; Maher L, 2018, 'Mental health, drug use and sexual risk behavior among gay and bisexual men', International Journal of Drug Policy, 55, pp. 169 - 179, http://dx.doi.org/10.1016/j.drugpo.2018.01.020

Bui H; Zablotska-Manos I; Hammoud M; Jin F; Lea T; Bourne A; Iversen J; Bath N; Grierson J; Degenhardt L; Prestage G; Maher L, 2018, 'Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study', International Journal of Drug Policy, 55, pp. 222 - 230, http://dx.doi.org/10.1016/j.drugpo.2018.01.018

Hengel B; Bell S; Garton L; Ward J; Rumbold A; Taylor-Thomson D; Silver B; McGregor S; Dyda A; Knox J; Guy R; Maher L; Kaldor JM; STRIVE Investigators , 2018, 'Perspectives of primary health care staff on the implementation of a sexual health quality improvement program: a qualitative study in remote aboriginal communities in Australia.', BMC Health Serv Res, 18, pp. 230, http://dx.doi.org/10.1186/s12913-018-3024-y

Geddes L; Iversen J; Memedovic S; Maher L, 2018, 'Intravenous fentanyl use among people who inject drugs in Australia', Drug and Alcohol Review, 37, pp. S314 - S322, http://dx.doi.org/10.1111/dar.12668

Ward Z; Sweeney S; Platt L; Guinness L; Maher L; Hope V; Hickman M; Smith J; Ayres R; Hainey I; Chamberlain T; Vickerman P, 2018, 'The cost-effectiveness of needle and syringe provision in preventing transmission of Hepatitis C virus in people who inject drugs', JOURNAL OF HEPATOLOGY, 68, pp. S146 - S147, http://dx.doi.org/10.1016/S0168-8278(18)30508-7

Hammoud MA; Vaccher S; Jin F; Bourne A; Haire BG; Maher L; Lea T; Prestage G, 2018, 'The new MTV generation: Using methamphetamine, Truvada and Viagra to enhance sex and stay safe.', International Journal of Drug Policy, 55, pp. 197 - 204, http://dx.doi.org/10.1016/j.drugpo.2018.02.021

Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M, 2018, 'Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis', Addiction, 113, pp. 545 - 563, http://dx.doi.org/10.1111/add.14012

Doyle M; Maher L; Graham S; Wand H; Iversen J, 2018, 'Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs', Australian and New Zealand Journal of Public Health, 42, pp. 52 - 56, http://dx.doi.org/10.1111/1753-6405.12741

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, 23, pp. 425 - 433, http://dx.doi.org/10.3851/IMP3219

Maher L; Dertadian G, 2018, 'Qualitative research', Addiction, 113, pp. 167 - 172, http://dx.doi.org/10.1111/add.13931

Esmaeili A; Mirzazadeh A; Morris MD; Hajarizadeh B; Sacks HS; Maher L; Grebely J; Kim AY; Lauer G; Cox AL; Hellard M; Dietze P; Bruneau J; Shoukry NH; Dore GJ; Lloyd AR; Prins M; Page K, 2018, 'The Effect of Female Sex on Hepatitis C Incidence among People Who Inject Drugs: Results from the International Multicohort InC3 Collaborative', Clinical Infectious Diseases, 66, pp. 20 - 28, http://dx.doi.org/10.1093/cid/cix768

Hammoud MA; Bourne A; Maher L; Jin F; Haire B; Lea T; Degenhardt L; Grierson J; Prestage G, 2017, 'Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gamma-hydroxybutyrate for chemsex among Australian gay and bisexual men – results from the Flux Study', Sexual Health, 15, pp. 123 - 134, http://dx.doi.org/10.1071/SH17146

Muth S; Len A; Evans JL; Phou M; Chhit S; Neak Y; Ngak S; Stein ES; Carrico AW; Maher L; Page K, 2017, 'HIV treatment cascade among female entertainment and sex workers in Cambodia: Impact of amphetamine use and an HIV prevention program', Addiction Science and Clinical Practice, 12, pp. 20, http://dx.doi.org/10.1186/s13722-017-0085-x

Prestage G; Hammoud M; Lea T; Jin F; Maher L, 2017, 'Measuring drug use sensation-seeking among Australian gay and bisexual men', International Journal of Drug Policy, 49, pp. 73 - 79, http://dx.doi.org/10.1016/j.drugpo.2017.07.027

Bell S; Aggleton P; Ward J; Maher L, 2017, 'Sexual agency, risk and vulnerability: a scoping review of young Indigenous Australians’ sexual health', Journal of Youth Studies, 20, pp. 1208 - 1224, http://dx.doi.org/10.1080/13676261.2017.1317088

Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA, 2017, 'Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships', International Journal of Drug Policy, 48, pp. 54 - 62, http://dx.doi.org/10.1016/j.drugpo.2017.05.030

Quinn B; Seed C; Keller A; Maher L; Wilson D; Farrell M; Caris S; Williams J; Madden A; Thompson A; Pink J; Hellard ME, 2017, 'Re-examining blood donor deferral criteria relating to injecting drug use', International Journal of Drug Policy, 48, pp. 9 - 17, http://dx.doi.org/10.1016/j.drugpo.2017.05.058

Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M, 2017, 'Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs', Cochrane Database of Systematic Reviews, 2017, pp. cd012021, http://dx.doi.org/10.1002/14651858.CD012021.pub2

Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L, 2017, 'Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia', International Journal of Drug Policy, 47, pp. 77 - 85, http://dx.doi.org/10.1016/j.drugpo.2017.05.022

Bajis S; Dore GJ; Hajarizadeh B; Cunningham EB; Maher L; Grebely J, 2017, 'Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review', International Journal of Drug Policy, 47, pp. 34 - 46, http://dx.doi.org/10.1016/j.drugpo.2017.07.002

Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701

Dertadian GC; Dixon TC; Iversen J; Maher L, 2017, 'Self-limiting non-medical pharmaceutical opioid use among young people in Sydney, Australia: An exploratory study', Drug and Alcohol Review, 36, pp. 643 - 650, http://dx.doi.org/10.1111/dar.12474

Graham S; Maher L; Wand H; Doyle M; Iversen J, 2017, 'Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996–2015', International Journal of Drug Policy, 47, pp. 69 - 76, http://dx.doi.org/10.1016/j.drugpo.2017.06.007

Dertadian GK; Dixon T; Iversen J; Maher L, 2017, 'Pharmaceutical Opioid Use Among Oral and Intravenous Users in Australia: A Comparative Study.', International Journal of Drug Policy

Bui HTM; Le GM; Mai AQ; Zablotska-Manos I; Maher L, 2017, 'Barriers to access and uptake of antiretroviral therapy among HIV-positive men who have sex with men in Hanoi, Vietnam: from HIV testing to treatment', Culture Health and Sexuality, 19, pp. 859 - 872, http://dx.doi.org/10.1080/13691058.2016.1269203

Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F, 2017, 'Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms', International Journal of Drug Policy, 46, pp. 28 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.05.005

Hammoud MA; Jin F; Lea T; Maher L; Grierson J; Prestage G, 2017, 'Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results From the FLUX Study', Journal of Sexual Medicine, 14, pp. 774 - 784, http://dx.doi.org/10.1016/j.jsxm.2017.04.670

Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652

Hengel B; Wand H; Ward J; Rumbold A; Garton L; Taylor-Thomson D; Silver B; McGregor S; Dyda A; Mein J; Knox J; Maher L; Kaldor J; Guy R; Donovan B; Han A, 2017, 'Patient, staffing and health centre factors associated with annual testing for sexually transmissible infections in remote primary health centres.', Sexual Health, 14, pp. 274 - 281, http://dx.doi.org/10.1071/SH16123

Iversen J; Dertadian GK; Geddes L; Maher L, 2017, 'High Risk Injecting Behaviour Among People Who Inject Pharmaceutical Opioids in Australia.', International Journal of Drug Policy

Morris MD; Shiboski S; Bruneau J; Hahn JA; Hellard M; Prins M; Cox AL; Dore G; Grebely J; Kim AY; Lauer GM; Lloyd A; Rice T; Shoukry N; Maher L; Page K, 2017, 'Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: The InC3 collaboration', Clinical Infectious Diseases, 64, pp. 860 - 869, http://dx.doi.org/10.1093/cid/ciw869

Iversen J; Dertadian G; Geddes L; Maher L, 2017, 'High risk injecting behaviour among people who inject pharmaceutical opioids in Australia', International Journal of Drug Policy, 42, pp. 1 - 6, http://dx.doi.org/10.1016/j.drugpo.2016.12.004

Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA, 2017, 'Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection', Infection Genetics and Evolution, 49, pp. 88 - 96, http://dx.doi.org/10.1016/j.meegid.2017.01.006

Damon W; Small W; Anderson S; Maher L; Wood E; Kerr T; McNeil R, 2017, '‘Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation', Drug and Alcohol Review, 36, pp. 253 - 260, http://dx.doi.org/10.1111/dar.12411

Hammoud MA; Jin F; Degenhardt L; Lea T; Maher L; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Prestage GP, 2017, 'Following Lives Undergoing Change (Flux) study: Implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in Australia', International Journal of Drug Policy, 41, pp. 41 - 50, http://dx.doi.org/10.1016/j.drugpo.2016.11.012

Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L, 2017, 'Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study', International Journal of Drug Policy, 41, pp. 51 - 58, http://dx.doi.org/10.1016/j.drugpo.2016.12.007

McNeil R; Kerr T; Coleman B; Maher L; Milloy MJ; Small W, 2017, 'Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative', AIDS and Behavior, 21, pp. 402 - 409, http://dx.doi.org/10.1007/s10461-016-1470-2

Maher L; White B; Day C; Black K, 2017, 'Pregnancy incidence and contraceptive use among young women who inject drugs in Sydney, Australia', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E127 - E127, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.352

Eltahla AA; Leung P; Pirozyan MR; Rodrigo C; Grebely J; Applegate T; Maher L; Luciani F; Lloyd AR; Bull RA, 2017, 'Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment', Scientific Reports, 7, pp. 41719, http://dx.doi.org/10.1038/srep41719

Dertadian GK; Dixon T; Iversen J; Maher L, 2017, 'Self-limiting Non-Medical Pharmaceutical Opioid Use among Young People in Sydney, Australia: An Exploratory Study.', Drug and Alcohol Review

Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161

Eltahla AA; Rodrigo C; Betz-Stablein B; Grebely J; Applegate T; Luciani F; Schinkel J; Dore GJ; Page K; Bruneau J; Morris MD; Cox AL; Kim AY; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd AR; Bull RA, 2017, 'Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents', Journal of Viral Hepatitis, 24, pp. 37 - 42, http://dx.doi.org/10.1111/jvh.12615

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087

Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR, 2017, 'Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study', Journal of Viral Hepatitis, 24, pp. 43 - 52, http://dx.doi.org/10.1111/jvh.12616

Platt L; Sweeney S; Ward Z; Guinness L; Hickman M; Hope V; Hutchinson S; Maher L; Iversen J; Craine N; Taylor A; Munro A; Parry J; Smith J; Vickerman P, 2017, 'Assessing the impact and cost-effectiveness of needle/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling', Public Health Research, 5, pp. 1 - 118, http://dx.doi.org/10.3310/phr05050

Iversen J; Grebely J; Catlett B; Cunningham P; Dore GD; Maher L, 2017, 'O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies', Journal of Virus Eradication, 3, pp. 4, http://dx.doi.org/10.1016/s2055-6640(20)30892-x

Bajis S; Lamoury F; Applegate TL; Maher L; Treloar C; Mowat Y; Schulz M; Hajarizadeh B; Marshall A; Cunningham E; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Dore GJ; Grebely J; Group OBOTLS, 2017, 'P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people', Journal of Virus Eradication, 3, pp. 13 - 14, http://dx.doi.org/10.1016/s2055-6640(20)30745-7

Kishore S; Maher L; Majithia V, 2017, 'Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace', Current Rheumatology Reports, 19, pp. 39, http://dx.doi.org/10.1007/s11926-017-0667-3

Maher L; Dixon D, 2016, 'Cheaper drugs as crime control? Rethinking the drugs/crime nexus', Dialectical Anthropology, 40, pp. 343 - 348, http://dx.doi.org/10.1007/s10624-016-9419-4

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Back to profile page